Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Apr 24, 2007	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001206774-07-001113.pdf 0001206774-07-001113.xls
Apr 17, 2007	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-07-000024.pdf 0001237899-07-000024.xls
Apr 17, 2007	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-07-000025.pdf 0001237899-07-000025.xls
Apr 17, 2007	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-07-000026.pdf 0001237899-07-000026.xls
Apr 17, 2007	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-07-000027.pdf 0001237899-07-000027.xls
Apr 11, 2007	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-07-000023.pdf 0001237899-07-000023.xls
Apr 03, 2007	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-07-004963.pdf 0000950123-07-004963.xls
Mar 12, 2007	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0000950123-07-003627.pdf 0000950123-07-003627.xls
Mar 02, 2007	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-07-003120.pdf 0000950123-07-003120.xls
Feb 28, 2007	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-07-000020.pdf 0001237899-07-000020.xls

Data provided by Kaleidoscope.

Investors & Media